HAOHAI BIOTEC Calls 2025 AGM, Seeks 10% H-Share Buyback Mandate and Board Changes

Bulletin Express
Apr 28

Shanghai-based HAOHAI BIOTEC has scheduled its 2025 annual general meeting (AGM) for 29 May 2026 at 2:00 p.m. (24/F, WenGuang Plaza, Changning District, Shanghai). Shareholders will vote on ten resolutions—nine ordinary and one special—covering operational reports, profit allocation, board remuneration, auditor appointments, share repurchases and board composition.

Key agenda items 1. Operational and financial oversight: Shareholders will review the 2025 Board Work Report and the 2025 Financial Report. 2. Capital return: A 2025 Profit Distribution Plan and authority for the Board to declare 2026 interim dividends are up for approval. 3. Board remuneration: The 2026 director remuneration plan and a broader remuneration management policy for directors and senior executives will be presented. 4. Auditor appointments: The Company proposes assigning auditors for both its 2026 financial statements and internal control review. 5. Board changes: • Election of Ms. Tian Min as an executive director. • Election of Mr. Chan Sui Yu, Mr. Song Yuanyang and Ms. Xu Duoqi as independent non-executive directors. 6. Share buyback mandate (special resolution): The Board seeks authority to repurchase up to 10% of issued H shares (excluding treasury and uncancelled repurchased shares) during the mandate period, ending at the 2026 AGM or upon earlier revocation. The mandate empowers the Board to set price, volume and timing; manage regulatory filings; cancel repurchased shares; and amend the Articles of Association to reflect capital changes.

Share registration details • H-share register closure: 26 May 2026–29 May 2026 (both days inclusive). • Record date: 29 May 2026. • Last day to lodge H-share transfers: 22 May 2026, by 4:30 p.m. at Computershare Hong Kong Investor Services Limited (Shops 1712-1716, 17/F, Hopewell Centre, Wanchai).

All AGM resolutions will be decided by poll. Shareholders or authorised proxies may attend; legal-person shareholders must present appropriate board or governing-body authorisation. The meeting is expected to conclude within half a day, and participants will bear their own travel and accommodation costs.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10